Promising Cancer Research Treatment Breakthrough Seeks Funding for Corroboration of Results

Share Article

Groundbreaking cancer research treatment breakthrough seeks funding for corroboration of results.

Promising cancer research treatment breakthrough seeks funding for corroboration.

Helped by local, national, and international professionals and companies for nearly twelve years, CHAI Foundation, a small 501(c)(3) non-profit medical research organization seeking to find an effective but less toxic form of cancer chemotherapy, believes they have confirmed an anti-cancer material which enhances the immune system by particularly enhancing Beta cells, causing them in turn to strengthen specific anti-cancer antibodies.

An earlier small clinical study of the anti-cancer material done outside the U.S. appears to show effectiveness on several organ sites without the toxicity of today's modalities. These included
patients exhibiting lesions in one or more sites of the breast, skin, liver, lung, spine, pancreas, prostate, ovary, and stomach. In addition, some effectiveness was seen in an instance of lymphoid leukemia, and one of a glioma of the ocular nerve - showing the drug's ability to cross the brain barrier. Because of this, we theorize that cancer - contrary to current opinion - may indeed be one disease rather than scores of diseases.

CHAI Foundation believes they know what the anti-cancer material is, and possibly where it originates.

It is also theorized that with further study the material could be made into a vaccine.

A preliminary patent application has been filed.

CHAI Foundation is currently seeking corroboration of their findings by another cancer research organization, Pharma company, or independent laboratory.

For any questions, please contact CHAI Foundation at 602-996-6291 between 9:00 AM - 5:00 PM (MST).

Eroca Daniel, CEO
CHAI Foundation
POB 30603
Phoenix, AZ 85046
Phone: 602-996-6291 (MST)
Web: http://www.chaifoundation.org

###

Share article on social media or email:

View article via:

Pdf Print